Table II.
Comparisons between normal and hyperuricemia groups
| Variables | Normal (n = 137) | Hyperuricemia (n = 85) |
|---|---|---|
| Age [years] | 45.3 ±15.9 | 47.9 ±17.2 |
| Male | 80 (58.4%) | 52 (61.2%)# |
| Smoker | 54 (39.4%) | 33 (38.8%) |
| Systolic BP [mm Hg] | 125.4 ±7.9 | 132.1 ±7.3# |
| Diastolic BP [mm Hg] | 77.6 ±6.8 | 78.9 ±7.5 |
| Heart rate [bpm] | 73.7 ±12.8 | 72.0 ±11.4 |
| Total cholesterol [mmol/l] | 5.1 ±1.4 | 5.0 ±1.1 |
| Triglyceride [mmol/l]* | 1.8 (0.8–2.2) | 1.8 (0.9–2.3) |
| LDL-cholesterol [mmol/l] | 3.2 ±1.0 | 3.3 ±1.2 |
| HDL-cholesterol [mmol/l] | 1.1 ±0.6 | 1.2 ±0.5 |
| FPG [mg/dl] | 121.4 ±14.2 | 124.6 ±15.0 |
| Creatinine [µmol/l] | 58.7 ±10.3 | 61.4 ±11.7 |
| eGFR [ml/min/1.73 m2] | 96.1 ±5.2 | 94.5 ±4.3 |
| Hs-CRP [mg/dl] | 3.9 ±2.2 | 4.5 ±3.0# |
| UA [mg/dl] | 3.5 ±1.4 | 5.7 ±0.7# |
| Diabetes mellitus | 40 (29.2%) | 25 (29.4%) |
| Dyslipidemia | 44 (32.1%) | 28 (32.9%) |
| Aspirin | 42 (30.7%) | 28 (32.9%) |
| Statins | 36 (26.3%) | 22 (25.9%) |
| Hypoglycemic medication | 35 (25.5%) | 23 (27.1%) |
| Insulin | 12 (8.8%) | 8 (9.4%) |
| FMD (%) | 5.6 ±2.4 | 4.8 ±2.0# |
BP – blood pressure, LDL – low density lipoprotein, HDL – high density lipoprotein, eGFR – estimated glomerular filtration rate, hs-CRP – high sensitivity C-reactive protein, UA – uric acid, FMD – flow mediated dilation;
*
presented as median and quartiles;
#
p < 0.05 versus normal group.